汉森制药(002412) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 was CNY 218,470,759.89, an increase of 0.76% year-on-year, while the revenue for the year-to-date period reached CNY 681,150,652.08, up 3.22% compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2022 was CNY 51,192,368.36, representing a growth of 19.45% year-on-year, and the year-to-date net profit was CNY 130,074,008.87, an increase of 14.61%[4] - The basic earnings per share for Q3 2022 was CNY 0.1017, up 19.37% year-on-year, with diluted earnings per share also at CNY 0.1017[4] - Total operating revenue for the period reached ¥681,150,652.08, an increase of 3.7% compared to ¥659,918,134.34 in the previous period[22] - Net profit attributable to shareholders was ¥130,074,008.87, representing a 14.6% increase from ¥113,492,866.04 year-over-year[23] - Basic and diluted earnings per share increased to ¥0.2585 from ¥0.2255, reflecting a growth of 14.0%[24] Assets and Liabilities - Total assets at the end of Q3 2022 amounted to CNY 2,326,803,516.30, reflecting a growth of 10.21% compared to the end of the previous year[4] - The total assets of the company reached ¥2,326,803,516.30, an increase from ¥2,111,282,192.35 at the beginning of the year, reflecting a growth of 10.2%[20] - The company's accounts receivable rose to ¥244,069,859.79, compared to ¥207,401,998.50 at the start of the year, indicating an increase of 17.6%[20] - The total liabilities rose to ¥454,999,569.04, compared to ¥368,989,659.95 in the previous period, marking a 23.3% increase[23] - The total liabilities include accounts payable of ¥37,720,362.29, down from ¥51,440,181.32, indicating a decrease of 26.7%[20] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 99,673,861.60 year-to-date, a significant decrease of 44.28% compared to the same period last year[4] - Cash flow from operating activities decreased to ¥715,181,968.17 from ¥779,328,523.24, a decline of 8.2%[25] - The net cash flow from operating activities for Q3 2022 was ¥99,673,861.60, a decrease of 44.3% compared to ¥178,868,988.40 in Q3 2021[26] - The total cash inflow from operating activities was ¥727,909,881.30, compared to ¥793,862,474.10 in the same quarter last year[26] - The total cash outflow from operating activities was ¥628,236,019.70, slightly higher than ¥614,993,485.70 in Q3 2021[26] Investments and Financing - The net cash flow from investing activities increased by 59.84% year-on-year, primarily due to an increase in cash received from purchasing bank wealth management and structured deposit products[11] - The net cash flow from financing activities increased by 432.43% year-on-year, mainly due to an increase in cash received from bank loans amounting to CNY 20,000,000[13] - Total cash inflow from investment activities was ¥105,725,650.98, significantly higher than ¥9,451,927.51 in the previous year[26] - The net cash flow from investment activities was -¥60,548,911.08, improving from -¥150,779,901.61 in Q3 2021[26] - Cash inflow from financing activities totaled ¥151,504,745.40, up from ¥130,153,195.20 in the same quarter last year[26] - The net cash flow from financing activities was ¥18,628,464.93, a turnaround from -¥5,603,689.48 in Q3 2021[26] Shareholder Information - The company’s total equity attributable to shareholders at the end of Q3 2022 was CNY 1,871,803,947.26, a growth of 7.43% compared to the end of the previous year[4] - The total equity attributable to shareholders increased to ¥1,871,803,947.26, up from ¥1,742,292,532.40, a growth of 7.4%[23] - The total number of common shareholders at the end of the reporting period is 33,824[15] - The largest shareholder, Hainan Hansen Holdings (Limited Partnership), holds 42.13% of the shares, totaling 212,006,189 shares[15] Other Income and Expenses - The company’s other income increased by 208.05% year-on-year, mainly due to a tax reward received from the local government amounting to CNY 2,844,100.00[9] - Research and development expenses for the period were ¥33,008,550.96, compared to ¥26,339,208.61 in the previous period, indicating a 25.4% increase[23] - Other comprehensive income after tax decreased to -¥1,912,591.42 from ¥7,803,735.27, reflecting a significant decline[24] - The total comprehensive income for the period was ¥128,161,417.45, compared to ¥121,296,601.31 in the previous period, an increase of 5.7%[24] Audit Information - The company did not undergo an audit for the Q3 report[28]